• column
  • column
    • Home
    • About Us
      • Our vision
      • Our team
      • Our founders
      • News & Resources
      • Case Studies
      • Clients
      • Advisory board
  • column
    • Our Services
      • How we work
      • Project partners
    • Preclinical Research Services
    • Clinical Trial Volunteer Opportunities
    • Clinical Trials Services
  • column
    • Contact
      • Companies
      • Volunteers
    • FOLLOW US
      • X
      • Linkedin
      • Facebook
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.

Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.

by Virtus | Nov 3, 2019

Click the button below to read more about this. CLICK HERE FOR...
Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of COPD.

Oxidative and nitrosative stress and histone deacetylase-2 activity in exacerbations of COPD.

by Virtus | Nov 3, 2019

Click the button below to read more about this. CLICK HERE FOR...
Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens.

by Virtus | Nov 3, 2019

Click the button below to read more about this. CLICK HERE FOR...
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Role of deficient type III interferon-lambda production in asthma exacerbations.

Role of deficient type III interferon-lambda production in asthma exacerbations.

by Virtus | Sep 18, 2019

Click the button below to read more about this. CLICK HERE FOR...
Next Entries »

Recent Posts

  • Preclinical Efficacy Testing in Respiratory Drug Development
  • Outsourcing vs In-House Respiratory Research: Which Approach Is Right for Preclinical Drug Development?
  • Viral Challenge Preclinical Studies in Respiratory Drug Development
  • Respiratory CRO in the UK: How to Evaluate Preclinical Respiratory Research Partners
  • Asthma vs COPD Preclinical Models in Respiratory Drug Development

Recent Comments

No comments to show.

Privacy Notice and Cookie Policy





All content © 2022 Virtus Respiratory Research. All Rights Reserved.

Contact